Forma Therapeutics Holdings, Inc.

Ownership Transactions Reported by 18 Insiders

Industry
Biological Products, (No Diagnostic Substances)
Location
300 North Beacon Street, Suite 501, Watertown, Massachusetts

There are no Buy or Sell transactions made by insiders since 7/8/2023

Forma Therapeutics Holdings, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Peter Kolchinsky Director, 10%+ Owner $45.5 M Jun 17, 2021
Mary E. Wadlinger Officer $679 K Feb 23, 2022
Patrick F. Kelly SVP, Chief Medical Officer $530 K Apr 13, 2022
David N. Cook SVP, Chief Scientific Officer $209 K Feb 28, 2022
Selwyn M. MD Vickers Director $36.6 K Jun 8, 2022
Brian Andrew Lesser SVP, Commercial Officer Oct 14, 2022
Jeannette Potts Officer Title: SVP, General Counsel and Corporate Secretary Oct 14, 2022
Todd Shegog SVP, Chief Financial Officer Oct 14, 2022
Frank D. Lee President and CEO, Director Oct 14, 2022
Agustin Melian EVP, Research & Development Oct 14, 2022
Timothy P. Clackson Director Oct 14, 2022
Ra Capital Management, L.P. Director, 10%+ Owner Oct 14, 2022
Wayne A.I. Frederick Director Oct 14, 2022
Arturo Molina Director Oct 14, 2022
Marsha Fanucci Director Oct 14, 2022
Wirth Peter Director Oct 14, 2022
Thomas G. Wiggans Director Oct 14, 2022
John E. Bishop SVP, Chief Technology Officer Oct 14, 2022

Recent Insider Transactions by Companies or Individuals for Forma Therapeutics Holdings, Inc.

Insider Class Transaction % Value $ Price $ Shares Shares Owned Date Ownership